RTW INVESTMENTS, LP purchased 800K shares of PROMETHEUS BIOSCIENCES, INC. on the open market
Open‑market purchase worth $15.20M. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/16/2021ACC: 0001493152-21-006147
10% Owner
Since Mar 2021
-21.38M
Net shares
Net seller
$15.20M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
3.26M acquired · 24.64M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+800K
Price / share
$19.00
Trade value
$15.20M
% of position
New position
3/16/2021
0.00→800K
Common Stock
Indirect
Shares
+1.02M
Price / share
—
Trade value
—
% of position
127.2%
3/16/2021
800K→1.82M
Common Stock
Indirect
Shares
+1.45M
Price / share
—
Trade value
—
% of position
79.6%
3/16/2021
1.82M→3.26M
Total
Net shares
+3.26M
Net value
$15.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/16/2021 | P · Purchase | +800K | $19.00 | $15.20M | New position | 0.00 | 800K |
| Common Stock Indirect | 3/16/2021 | C · Conversion | +1.02M | — | — | 127.2% | 800K | 1.82M |
| Common Stock Indirect | 3/16/2021 | C · Conversion | +1.45M | — | — | 79.6% | 1.82M | 3.26M |
| Total | +3.26M | $15.20M | ||||||
Derivative Transactions2
Series D-1 Preferred Stock
Indirect
Converts to
Common Stock
1.02M shares
Shares
−10.18M
Strike price
Held after
0.00
Exercisable
—
3/16/2021
Series D-2 Preferred Stock
Indirect
Converts to
Common Stock
1.45M shares
Shares
−14.46M
Strike price
Held after
0.00
Exercisable
—
3/16/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series D-1 Preferred Stock Indirect | Common Stock1.02M shares | 3/16/2021 | C · Conversion | −10.18M | — | 0.00 | |
| Series D-2 Preferred Stock Indirect | Common Stock1.45M shares | 3/16/2021 | C · Conversion | −14.46M | — | 0.00 |